about
Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.Continuous vancomycin in a pediatric cystic fibrosis patient.Highlights from the 2017 North American Cystic Fibrosis ConferenceChallenging scenarios in nontuberculous mycobacterial infection in cystic fibrosisHighlights from the 2018 North American cystic fibrosis conferenceMucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis
P50
description
researcher
@en
wetenschapper
@nl
name
Charles R Esther
@en
Charles R Esther
@nl
type
label
Charles R Esther
@en
Charles R Esther
@nl
prefLabel
Charles R Esther
@en
Charles R Esther
@nl
P31
P496
0000-0002-8081-2986